Reviva Pharmaceuticals RVPH
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 5.58 | 0.32 | -3,559 | -3 | ||
| 2025Q3 | 7.37 | 100.62 | -0.80 | -4,030 | -4 | |
| 2025Q2 | 7.62 | 100.53 | -2.40 | -6,073 | -6 | |
| 2025Q1 | 19.08 | 101.90 | -2.60 | -6,538 | -6 | |
| 2024Q4 | 36.20 | 100.56 | -2.73 | -6,285 | -6 | |
| 2024Q3 | 28.80 | 101.22 | -4.80 | -8,463 | -8 | |
| 2024Q2 | 25.60 | 103.59 | -5.20 | -8,130 | -8 | |
| 2024Q1 | 75.60 | 106.72 | -5.00 | -7,922 | -7 | |
| 2023Q4 | 103.00 | 102.55 | -6.60 | -9,619 | -9 | |
| 2023Q3 | 97.60 | 102.10 | -9.60 | -11,195 | -11 | |
| 2023Q2 | 117.20 | 97.10 | -10.60 | -11,821 | -12 | |
| 2023Q1 | 83.80 | 102.18 | -6.20 | -6,736 | -7 | |
| 2022Q4 | 85.00 | 95.86 | -11.60 | -7,774 | -8 | |
| 2022Q3 | 31.80 | 101.42 | -3.60 | -3,563 | -4 | |
| 2022Q2 | 22.00 | 103.49 | -5.80 | -5,519 | -5 | |
| 2022Q1 | 49.20 | 101.21 | -8.00 | -7,450 | -7 | |
| 2021Q4 | 57.80 | 107.60 | -4.40 | -3,965 | -4 | |
| 2021Q3 | 81.40 | 108.78 | -2.60 | -2,477 | -2 | |
| 2021Q2 | 97.20 | 111.59 | -2.60 | -1,791 | -2 | |
| 2021Q1 | 114.80 | 197.47 | -2.00 | -1,872 | -1 |